Press Releases
Please view the latest press from Enzo Biochem, Inc.
| Date | Details |
| Monday, December 15, 2003 | ENZO Biochem Reports Operating Results For Fiscal 2004 First Quarter |
| Thursday, November 06, 2003 | ENZO Biochem Gene Vector for HIV Cleared to Begin Phase I/II Clinical Trial at New York Presbyterian Hospital-Weill Medical College of Cornell University |
| Wednesday, October 29, 2003 | ENZO Biochem Reports Operating Results for Fiscal Year Ended July 31, 2003 |
| Tuesday, October 28, 2003 | ENZO Biochem Says Lawsuit Filed Against Affymetrix for Breach of Agreement |
| Monday, October 27, 2003 | ENZO Biochem Develops New Therapeutic Platforms to Treat Immune-Mediated Diseases |
| Tuesday, September 16, 2003 | ENZO Biochem Reports on Meeting in Israel |
| Monday, September 15, 2003 | ENZO Biochem to Present at UBS Global Life Sciences Conference |
| Monday, June 16, 2003 | ENZO Biochem Announces Third Quarter and Nine Months Operating Results. Board of Directors Declares 5% Stock Dividend. |
| Monday, June 09, 2003 | ENZO Biochem Initiates Phase II Study of Crohn’s Disease Treatment. |
| Tuesday, May 20, 2003 | ENZO Biochem Reports Phase I Clinical Trial Results of a New Mode of Crohn’s Disease Treatment. Seven of 10 Subjects Achieved Clinical Remission During Trial. ENZO to Initiate Phase II Study |
| Friday, March 14, 2003 | ENZO Biochem Reports Continuing Growth in Second Quarter Operating Results |
| Monday, March 10, 2003 | ENZO Biochem Announces Settlement with Two Companies in Patent Suit |
| Thursday, January 23, 2003 | ENZO Biochem Tells Shareholders Meeting it Expects Further Progress in Operating Results and Product Development Plans |
| Wednesday, January 15, 2003 | ENZO Biochem Comments on FDA Action |